Current priorities
hsCRP 4.8 — High CV Risk
0.4 → 1.1 → 4.8 mg/L. Acute inflammatory process likely. Retest when well, 48h rest. If persistent >3.0, investigate.
WBC 13.5 / Neutrophils 10.3
Leukocytosis with neutrophilia. Pattern suggests acute infection/inflammation. Correlate with symptoms. Repeat FBC in 2–4 weeks.
Renal: Urea/Creat/eGFR flagged
Urea 8.6, Creat 110, eGFR 79. Likely dehydration + high protein + acute illness. Hydrate, retest when well.
Testosterone Drop: 23.5 → 18.2
Significant decline. Acute phase suppression probable. Also new lab (GHJ vs SNP). Free T pending. Retest when well.
LDL 3.1 & Total Chol 5.4 Flagged
LDL rising: 1.93 → 2.2 → 2.8 → 3.1. Review dietary saturated fat. Monitor ApoB. Recheck fasted lipids.
Free T3 Resolved
fT3 4.8 pmol/L (3.5–6.0). Normal. Previously missing — now available. TSH 1.14, fT4 17.2 — euthyroid, no conversion issue.
Fasted Insulin: 2.3
First confirmed fasted draw. Low-normal = excellent insulin sensitivity. Lab flagged low but this is desirable for a lean 25yo.
Hep B Vaccination
Dose 1 Mar 2026. Dose 2 due Apr 2026. Dose 3 ~Sep 2026. Recheck surface Ab 4–8 weeks after dose 3.
Free Testosterone Pending
Result shown as "In Progress". Chase lab. Critical for understanding SHBG-normalisation impact.
Hormones
Total Testosterone
Drop
18.2
nmol/L
Apr 25 → Jun 25 → Mar 26 → Apr 26
↘
20.8 → 23.3 → 23.5 → 18.2 nmol/L. Acute drop, likely illness/inflammation related. Retest when well. New lab (GHJ vs SNP).
SHBG
Elevated
46.2
nmol/L
Jun 2025 → Mar 2026 → Apr 2026
↘
54 → 52 → 46.2. Trending down (improving). Still upper-range. Different lab/reference range. Consider boron 6–10 mg/day.
Free Testosterone
Pending
—
"In Progress" per lab. Previously 350 → 370 pmol/L (calculated). Once available, recalculate with updated SHBG 46.2.
LH
Low-Normal
2.0
IU/L
Mar 2026 value. 3.2 → 1.9 → 2.0. Not re-tested Apr 2026. Stable individual set point.
FSH
Low-Normal
2.0
IU/L
Mar 2026 value. 2.4 → 2.4 → 2.0. Not re-tested Apr 2026.
Oestradiol
Normal
60
pmol/L
Mar 2026 value. Not re-tested Apr 2026.
Prolactin
Normal
267
mIU/L
Mar 2026 value. 197 → 267. Not re-tested Apr 2026.
DHEA-S
Upper-Mid
13.3
umol/L
Mar 2026 value. Not re-tested Apr 2026.
DHT
Normal
1.6
nmol/L
Jun 2025 only data point. LC-MS/MS method. Not re-tested.
IGF-1
Mid-Range
25
nmol/L
Jun 2025 only. GH axis baseline. Not re-tested.
Thyroid
TSH
Optimal
1.14
mIU/L
1.7 (2019) → 0.80 (2024) → 1.18 (Apr 2025) → 1.1 (Mar 2026) → 1.14 (Apr 2026). Rock solid, optimal zone.
Free T4
Normal
17.2
pmol/L
Mar 2026 → Apr 2026
↗
11.5 (Mar, low-quarter) → 17.2 (Apr, mid-normal). Previous low likely lab variance or acute-phase dip. No T4→T3 concern.
Free T3
Normal
4.8
pmol/L
First fT3 result. Mid-range normal. Resolves prior "missing" action item. TSH/fT4/fT3 all consistent — euthyroid, healthy axis.
TPO Antibodies
Normal
<1.0
IU/mL
Mar 2026. Ref <5.6. No autoimmune thyroid process.
Thyroglobulin Ab
Normal
2.1
IU/mL
Mar 2026 value. Not re-tested Apr 2026.
Metabolic
HbA1c
Excellent
5.0
%
4.9% (Jun 2024) → 5.3% (Mar 2026) → 5.0% (Apr 2026). All excellent. Method: Ion exchange HPLC.
Glucose (Fasted)
Optimal
4.0
mmol/L
First confirmed fasted glucose. Excellent. Prior: 5.4 (fasted, 2024), 4.1 (non-fasted, Mar 2026).
Insulin (Fasted)
Low-Normal
2.3
uIU/mL
Lab flagged LOW (<3.0) but this is excellent for a lean 25yo athlete. HOMA-IR ~0.2. Prior: 15 mU/L (Mar 2026, non-fasted — uninterpretable).
Uric Acid
Normal
0.38
mmol/L
0.34 (Jun 2024) → 0.38 (Apr 2026). Stable.
Lipids (Fasted?, Apr 2026)
Lipid Panel — Total Chol & LDL flagged
Warning
Total Chol
5.4 mmol/L
<5.2 ⚠
LDL
3.1 mmol/L
<2.6 ⚠
HDL
2.0 mmol/L
>1.0 ✓✓
Triglycerides
0.7 mmol/L
<1.7 ✓✓
Non-HDL
3.4 mmol/L
<3.4 ↑
ApoB
0.77 g/L
0.46–1.74
Lp(a)
<5 nmol/L
<75 ✓✓
Total:HDL
2.7 ratio
<3.5
LDL trend
LDL steadily rising throughout lean bulk. If >3.4 next draw, consider dietary fat quality review. ApoB 0.77 still reasonable.
Inflammation
hsCRP
High Risk
4.8
mg/L
0.4 (Jun 2025) → 1.1 (Mar 2026) → 4.8 (Apr 2026). Lab reference <3.1 — HIGH RISK. Consistent with acute illness/infection at time of draw. Retest when well, 48h rest, 24h no training. If persists >3.0, work up (gut, dental, chronic).
ESR
Optimal
1
mm/h
Mar 2026 only. Not re-tested Apr 2026.
Homocysteine
Borderline
8.6
umol/L
Mar 2026 only. Lab range normal. Functional target <8. B12 255 now available — adequate. Ensure folate, B6 sufficiency.
Iron / Haematology
Haemoglobin
Normal
155
g/L
136 (Jun 2024) → 150 → 146 → 155. Recovered from iron-limited anaemia. Best ever result.
Ferritin
Normal
83.4
ug/L
87 → 94 → 62 → 87 → 83.4. Functional target 80–150. Recovered from 2024 dip. Mildly lower-end — monitor during heavy training.
WBC
High
13.5
10⁹/L
7.1 (Mar 2026) → 13.5 (Apr 2026). Flagged HIGH. Neutrophil predominance — acute infection pattern. Repeat when well.
Neutrophils
High
10.3
10⁹/L
Mar 2026 → Apr 2026
↑↑
3.95 (Mar 2026) → 10.3 (Apr 2026). 76.4% of WBC. Acute bacterial/viral response. Correlates with CRP spike.
Lymphocytes
Low-%
1.8
10⁹/L
Absolute count normal but 13.4% (low) — relative lymphopenia due to neutrophil dominance. Not a primary concern.
Platelets
Normal
279
10⁹/L
247 → 279. Stable.
Haematocrit
Normal
0.47
L/L
0.43 → 0.47. Consistent with Hb improvement.
MCV
Normal
94
fL
89 → 94. High-normal. Neither micro nor macrocytic.
RBC
Normal
5.05
10¹²/L
First-time measured. Normal.
Eosinophils
High
0.49
10⁹/L
Mildly elevated absolute count (3.6%). Possible allergic/parasitic component. Correlate clinically.
Serum Iron
Normal
19
umol/L
Mar 2026 value. 5 (critical, Jun 2024) → 15.3 → 25.1 → 19. Not re-tested Apr 2026.
Vitamins & Minerals
Vitamin D
Sufficient
107
nmol/L
83 (Jun 25) → 93 (Mar 26) → 107 (Apr 26). Improving. Target 125–175. Continue 4,000 IU/day. Lab interpretation: "Sufficiency".
Vitamin B12
Normal
255
pmol/L
Total B12. Lab ref 156–672. Low-normal range. Prior: 93 pmol/L Active B12 (Mar 2026 — different assay, not comparable). 395 pmol/L total B12 (Jun 2024).
Folate (Serum)
Normal
18
nmol/L
Mar 2026 value. 32.8 (2024) → 18 (2026). Adequate. Not re-tested Apr 2026.
Magnesium (Serum)
Low-Quarter
0.77
mmol/L
Mar 2026 value. Lower quarter. Not re-tested. Continue supplementation.
Liver Function
ALT
Excellent
14
U/L
13 (Mar 2026) → 14. Excellent.
AST
Excellent
23
U/L
20 (Mar 2026) → 23. Was 40 (borderline, 2024 — training related). Normalised.
GGT
Excellent
10
U/L
6 (Mar 2026) → 10. Very low. No liver oxidative stress.
ALP
Normal
84
U/L
69 → 84. Normal. Different labs, different ranges.
Bilirubin
Normal
16.8
umol/L
12 → 16.8. Within range. Upwards trend but still normal.
Albumin
Optimal
49
g/L
47 → 49. Top of range — excellent nutritional status.
FIB-4 Score
Low Risk
0.57
Ref <1.30 (Low risk). First-time calculated. Excellent — no hepatic fibrosis risk.
Kidney & Electrolytes
Creatinine
High
110
umol/L
90 (Mar 2026) → 110 (Apr 2026). Mild elevation. Likely high protein intake + dehydration + acute illness. Monitor. Enzymatic method.
eGFR (CKD-EPI)
Low
79
mL/min
Previously >90. Now 79 (<90 threshold). Driven by creatinine rise. Likely transient. Hydrate and retest when well.
Urea
High
8.6
mmol/L
6.7 (Mar 2026) → 8.6 (Apr 2026). Consistent with high protein intake + dehydration + catabolic stress from illness.
Sodium
Normal
143
mmol/L
141 → 143. Normal.
Potassium
Normal
3.9
mmol/L
4.2 → 3.9. Normal range.
Corrected Calcium
Normal
2.34
mmol/L
2.32 → 2.34. Stable.
Gaps — Never Tested
Missing Baseline Tests
Todo
Free T3 — RESOLVED ✓
Fasted Insulin — RESOLVED ✓
Zinc (serum)
Copper / Ceruloplasmin
Cortisol (morning fasted)
Vitamin A
Omega-3 Index
GI-MAP stool test
DUTCH hormone panel
HOMA-IR (now calculable at ~0.2)
SHBG / Free T recheck when well